aTyr Pharma, Inc. (LIFE)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Feb 07, 2025

$3.90

P/E Ratio

N/A

Market Cap

$327.38M

Description
Add to research

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Metrics
Add to research

Overview

  • HQSan Diego, CA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerLIFE
  • Price$3.9+0.78%

Trading Information

  • Market cap$327.38M
  • Float97.60%
  • Average Daily Volume (1m)753,236
  • Average Daily Volume (3m)838,657
  • EPS-$0.94

Company

  • Revenue$0.24M
  • Rev growth (1yr)-100.00%
  • Net income-$17.26M
  • Gross marginN/A
  • EBITDA marginN/A
  • EBITDA-$17.76M
  • EV$80.81M
  • EV/Revenue343.86
  • P/EN/A
  • P/S1,257.99
  • P/B4.53
  • Debt/Equity20.77
Documents
Add to research